Evicenter
MarkdownMedical informationP&T meetings
Ersodetug (RZ358)

Tumor hyperinsulinism

Manufacturer
Rezolute
Launch
Not announced
Last updated
140 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Diazoxide

10 evidence topics · 11 sources

Indication, dosing, warnings, and adverse reactions: diazoxide prescribing information

“PROGLYCEM is indicated for the management of hypoglycemia due to hyperinsulinism associated with the following conditions: • Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy.” (opens the source at this quote in a new tab)

“PROGLYCEM may be used preoperatively as a temporary measure, and postoperatively, if hypoglycemia persists.” (opens the source at this quote in a new tab)

“When other specific medical therapy or surgical management either has been unsuccessful or is not feasible, treatment with PROGLYCEM should be considered.” (opens the source at this quote in a new tab)

“Adults and children: The recommended starting dosage is 3 mg/kg/day, administered orally, divided into 3 equal doses every 8 hours or 2 equal doses every 12 hours. The dosage may be titrated to a maximum of 8 mg/kg/day. Patients with refractory hypoglycemia may require higher dosages.” (opens the source at this quote in a new tab)

“If administration of PROGLYCEM is not effective after 2 or 3 weeks, discontinue PROGLYCEM.” (opens the source at this quote in a new tab)

“The antidiuretic property of diazoxide may lead to significant fluid retention. In patients with compromised cardiac reserve, fluid retention may precipitate congestive heart failure.” (opens the source at this quote in a new tab)

“Ketoacidosis and nonketotic hyperosmolar coma have been reported in patients treated with PROGLYCEM, usually during intercurrent illness.” (opens the source at this quote in a new tab)

“Hirsutism of the lanugo type, mainly on the forehead, back and limbs, occurs most commonly in children and women and may be cosmetically unacceptable.” (opens the source at this quote in a new tab)

“Thrombocytopenia with or without purpura may require discontinuation of PROGLYCEM.” (opens the source at this quote in a new tab)